Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 49

Sort by

Sort Order Select

Journal Articles

Single Cell Transcriptomics on Bone Marrow Biopsies Unveils Peculiar Bone Microenvironment Cell Subtypes and Highlights Alterations Correlated with High-Risk Features in Precursor Monoclonal Gammopathies and Multiple Myeloma Patients

Blood (2024) 144 (Supplement 1): 4656.

https://doi.org/10.1182/blood-2024-207574

Published: 2024

Journal Articles

PYGO2-MDR1 Axis in Multiple Myeloma Patients with 1q21 Amplification As Promising Target to Overcome Carfilzomib Resistance

Nicolas Thomas Iannozzi, Jessica Burroughs Garcia, Valentina Marchica, Valentina Franceschi, Denise Toscani, Rosanna Vescovini, Vincenzo Raimondi, Oxana Lungu, Giannalisa Todaro, Gabriella Sammarelli, Matteo Scita, Federica Librale, Anna Benedetta Dalla Palma, Gaetano Donofrio, Paola Storti, Luca Agnelli, Giancarlo Pruneri, Nicola Giuliani

Blood (2023) 142 (Supplement 1): 6575.

https://doi.org/10.1182/blood-2023-181685

Published: 2023

Journal Articles

A Novel Model Combining Circulating Absolute Monocyte Counts and a Four-Gene Monocyte Signature in Leukapheresis Identifies Lymphoma Patients at Very High Risk of Progression after Tisagenlecleucel or Axicabtagene Ciloleucel Therapy

Cristiana Carniti, Martina Magni, Nicole Caldarelli, Tommaso Torelli, Luca Agnelli, Eugenio Fardella, Daniele Lorenzini, Arianna Rigamonti, Sadhana Jonnalagadda, Giada Zanirato, Anisa Bermema, Silvia Brich, Anna Dodero, Annalisa Chiappella, Paolo Corradini

Blood (2023) 142 (Supplement 1): 4873.

https://doi.org/10.1182/blood-2023-188416

Published: 2023

Journal Articles

A 7-Gene Signature in Unmanipulated Leukaphereses Correlates with in-Vivo CAR T-Cell Expansion and Survival of Lymphoma Patients Receiving Tisagenlecleucel or Axicabtagene Ciloleucel Therapy

Cristiana Carniti, Nicole Caldarelli, Francesca Nanetti, Martina Magni, Emma Esposito, Tommaso Torelli, Luca Agnelli, Silvia Brich, Chiara Monfrini, Eugenio Fardella, Paolo Longoni, Daniele Lorenzini, Martina Pennisi, Annalisa Chiappella, Paolo Corradini

Blood (2022) 140 (Supplement 1): 641–643.

https://doi.org/10.1182/blood-2022-168796

Published: 2022

Journal Articles

Identification of the Proteasome Subunits PSMB4 and PSMD4 As Novel Targets in Multiple Myeloma Patients Carrying 1q21 Amplification

Jessica Burroughs Garcia, Paola Storti, Nicolas Thomas Iannozzi, Laura Notarfranchi, Denise Toscani, Valentina Marchica, Vincenzo Raimondi, Luca Agnelli, Valentina Franceschi, Giannalisa Todaro, Oxana Lungu, Matia Bernardi, Matteo Scita, Gabriella Sammarelli, Gaetano Donofrio, Anna Benedetta Dalla Palma, Nicola Giuliani

Blood (2022) 140 (Supplement 1): 6750–6751.

https://doi.org/10.1182/blood-2022-165974

Published: 2022

Journal Articles

PSMB4 and PSMD4 Are Correlated with 1q21 Amplification in CD138 + Plasma Cells: New Potential Druggable Targets in Myeloma Patients

Jessica Burroughs-Garcia, Paola Storti, Luca Agnelli, Denise Toscani, Valentina Marchica, Gabriella Sammarelli, Giannalisa Todaro, Vincenzo Raimondi, Valentina Franceschi, Naomi Soressi, Anna Benedetta Dalla Palma, Laura Notarfranchi, Gaetano Donofrio, Nicola Giuliani

Blood (2021) 138 (Supplement 1): 2657.

https://doi.org/10.1182/blood-2021-150198

Published: 2021

Journal Articles

A Compendium of Transcriptional and Mutational Data to Improve the Stratification of Peripheral T-Cell Lymphoma Subtypes

Blood (2017) 130 (Supplement 1): 3997.

https://doi.org/10.1182/blood.V130.Suppl_1.3997.3997

Published: 2017

Journal Articles

Peripheral T-Cell Lymphomas Not Otherwise Specified: Potential Novel Molecular Entities Based on Both Tumor and Microenvironment Cellular Components

Blood (2016) 128 (22): 4098.

https://doi.org/10.1182/blood.V128.22.4098.4098

Published: 2016

Journal Articles

Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target

Blood (2016) 128 (5): 667–679.

https://doi.org/10.1182/blood-2016-01-690743

Published: 2016

Includes: Supplemental data

Journal Articles

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts

Blood (2016) 127 (2): 221–232.

https://doi.org/10.1182/blood-2014-12-614503

Published: 2016

Includes: Supplemental data

Journal Articles

Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma

Fabrizio Accardi, MD, Martina Chiu, Marina Bolzoni, Paola Storti, PhD, Katia Todoerti, PhD, Luca Agnelli, Massimiliano Ferrari, MD, Gabriele Missale, MD, Franco Aversa, MD, Ovidio Bussolati, MD PhD, Nicola Giuliani, MD PhD

Blood (2014) 124 (21): 2067.

https://doi.org/10.1182/blood.V124.21.2067.2067

Published: 2014

Journal Articles

Overexpression of Pro-Osteoclastogenic Cytokine Receptors and Chemokines By Bone Marrow CD14 + Monocytes of Multiple Myeloma (MM) Patients As Compared to Smoldering MM (SMM) and Monoclonal Gammopathy of Uncertain Significance (MGUS): Role of Interleukin(IL)-21 Receptor/IL-21 Axis in MM-Induced Osteoclastogenesis

Marina Bolzoni, Domenica Ronchetti, Paola Storti, PhD, Daniela Guasco, Valentina Marchica, Luca Agnelli, PhD, Benedetta Dalla Palma, MD, Fabrizio Accardi, MD, Federica Costa, Denise Toscani, Sabrina Bonomini, Benjamin Thomas, PhD, Antonino Neri, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2014) 124 (21): 28.

https://doi.org/10.1182/blood.V124.21.28.28

Published: 2014

Journal Articles

Identification of a New Subclass of ALK Negative Anaplastic Large Cell Lymphoma Expressing Aberrant Levels of ERBB4 Transcripts

Irene Scarfò, Elisa Pellegrino, Ivo Kwee, Luca Agnelli, Elisabetta Mereu, Elisa Bergaggio, Francesco Abate, Rodolfo Machiorlatti, Katia Messana, Andrea Rinaldi, Enrico Tiacci, Sara Serra, Silvia Deaglio, Antonino Neri, Brunangelo Falini, Raul Rabadan, Francesco Bertoni, Giorgio Inghirami, MD, Roberto Piva

Blood (2014) 124 (21): 1679.

https://doi.org/10.1182/blood.V124.21.1679.1679

Published: 2014

Journal Articles

High-Throughput Sequencing For The Identification Of NOTCH1 mutations In Early Stage Chronic Lymphocytic Leukemia: Biological and Clinical Implications

Blood (2013) 122 (21): 1622.

https://doi.org/10.1182/blood.V122.21.1622.1622

Published: 2013

Journal Articles

Trascriptome Analysis of Bone Marrow CD14 + Monocytes Revealed Differential Expression Profiles in Symptomatic Multiple Myeloma (MM) Compared to Smoldering MM and Monoclonal Gammopathy of Undetermined Significance

Marco Peronaci, Paola Storti, PhD, Domenica Ronchetti, Luca Agnelli, PhD, Marina Bolzoni, Daniela Guasco, Denise Toscani, Benedetta Dalla Palma, MD, Sabrina Bonomini, Gabriella Sammarelli, PhD, Luisa Craviotto, MD, Antonino Neri, Franco Aversa, MD, Nicola Giuliani

Blood (2012) 120 (21): 1811.

https://doi.org/10.1182/blood.V120.21.1811.1811

Published: 2012

Journal Articles

B-Cell Receptor Configuration and Adverse Cytogenetics Are Associated with Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia

Blood (2012) 120 (21): 1780.

https://doi.org/10.1182/blood.V120.21.1780.1780

Published: 2012

Journal Articles

Analysis of Transcriptome, Mirnome and Genomic Profiles in Association with Clinical Outcome in a Prospective Series of Primary Plasma Cell Leukemia

Blood (2012) 120 (21): 3938.

https://doi.org/10.1182/blood.V120.21.3938.3938

Published: 2012

Journal Articles

The Expression Pattern of Small Nucleolar and Small Cajal Body-Specific RNAs Characterizes Distinct Molecular Subtypes of Multiple Myeloma

Domenica Ronchetti, Katia Todoerti, Giacomo Tuana, PhD, Luca Agnelli, PhD, Laura Mosca, PhD, Marta Lionetti, PhD, Sonia Fabris, PhD, Patrizia Colapietro, Monica Miozzo, Manlio Ferrarini, MD, Pierfrancesco Tassone, MD, Antonino Neri

Blood (2012) 120 (21): 3955.

https://doi.org/10.1182/blood.V120.21.3955.3955

Published: 2012

Journal Articles

Hypoxia-Inducible Factor (HIF)-1a Is A Therapeutic Target in Myeloma-Induced Angiogenesis and Bone Destruction in Vivo .

Marina Bolzoni, Paola Storti, PhD, Gaetano Donofrio, PhD, Irma Airoldi, PhD, Daniela Guasco, Denise Toscani, Marco Peronaci, Eugenia Martella, MD, Mirca Lazzaretti, PhD, Luca Agnelli, PhD, Ken Patrene, Cristina Mancini, MD, Martine Amiot, PhD, Antonino Neri, Simona Colla, Judith Anderson, Franco Aversa, MD, G. David Roodman, MD, PhD, Nicola Giuliani

Blood (2012) 120 (21): 2947.

https://doi.org/10.1182/blood.V120.21.2947.2947

Published: 2012

Journal Articles

Improved Risk Stratification in Myeloma Using Microrna-Based Classifier

Ping Wu, MBBS, MSc, Luca Agnelli, PhD, Brian A Walker, BSc, PhD, Katia Todoerti, David C Johnson, PhD, Martin Kaiser, MD, Christopher P Wardell, PhD, Walter M Gregory, PhD, Faith E. Davies, MD, Daniel Brewer, PhD, Antonino Neri, Gareth J. Morgan, MD PhD

Blood (2012) 120 (21): 932.

https://doi.org/10.1182/blood.V120.21.932.932

Published: 2012

NARROW

Single Cell Transcriptomics on Bone Marrow Biopsies Unveils Peculiar Bone Microenvironment Cell Subtypes and Highlights Alterations Correlated with High-Risk Features in Precursor Monoclonal Gammopathies and Multiple Myeloma Patients

PYGO2-MDR1 Axis in Multiple Myeloma Patients with 1q21 Amplification As Promising Target to Overcome Carfilzomib Resistance

A Novel Model Combining Circulating Absolute Monocyte Counts and a Four-Gene Monocyte Signature in Leukapheresis Identifies Lymphoma Patients at Very High Risk of Progression after Tisagenlecleucel or Axicabtagene Ciloleucel Therapy

A 7-Gene Signature in Unmanipulated Leukaphereses Correlates with in-Vivo CAR T-Cell Expansion and Survival of Lymphoma Patients Receiving Tisagenlecleucel or Axicabtagene Ciloleucel Therapy

Identification of the Proteasome Subunits PSMB4 and PSMD4 As Novel Targets in Multiple Myeloma Patients Carrying 1q21 Amplification

PSMB4 and PSMD4 Are Correlated with 1q21 Amplification in CD138 + Plasma Cells: New Potential Druggable Targets in Myeloma Patients

A Compendium of Transcriptional and Mutational Data to Improve the Stratification of Peripheral T-Cell Lymphoma Subtypes

Peripheral T-Cell Lymphomas Not Otherwise Specified: Potential Novel Molecular Entities Based on Both Tumor and Microenvironment Cellular Components

Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts

Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma

Identification of a New Subclass of ALK Negative Anaplastic Large Cell Lymphoma Expressing Aberrant Levels of ERBB4 Transcripts

High-Throughput Sequencing For The Identification Of NOTCH1 mutations In Early Stage Chronic Lymphocytic Leukemia: Biological and Clinical Implications

Trascriptome Analysis of Bone Marrow CD14 + Monocytes Revealed Differential Expression Profiles in Symptomatic Multiple Myeloma (MM) Compared to Smoldering MM and Monoclonal Gammopathy of Undetermined Significance

B-Cell Receptor Configuration and Adverse Cytogenetics Are Associated with Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia

Analysis of Transcriptome, Mirnome and Genomic Profiles in Association with Clinical Outcome in a Prospective Series of Primary Plasma Cell Leukemia

The Expression Pattern of Small Nucleolar and Small Cajal Body-Specific RNAs Characterizes Distinct Molecular Subtypes of Multiple Myeloma

Hypoxia-Inducible Factor (HIF)-1a Is A Therapeutic Target in Myeloma-Induced Angiogenesis and Bone Destruction in Vivo .

Improved Risk Stratification in Myeloma Using Microrna-Based Classifier

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only